히알루론산 기반 피부 필러 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 제품별, 지역별, 부문별 예측(2025-2033년)
Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product, By Region, And Segment Forecasts, 2025 - 2033
상품코드
:
1888774
리서치사
:
Grand View Research
발행일
:
2025년 11월
페이지 정보
:
영문 140 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
히알루론산 기반 피부 필러 시장 요약
세계의 히알루론산 기반 피부 필러 시장 규모는 2024년에 44억 7,000만 달러로 추정되며, 2033년까지 110억 달러에 달할 것으로 예측됩니다.
2025년부터 2033년까지 CAGR 10.5%로 성장할 것으로 예상됩니다. 시장 성장을 이끄는 주요 요인은 비침습적 미용 시술에 대한 수요 증가와 미용 분야에서의 히알루론산(HA) 적용에 대한 인지도 향상입니다.
미국 성형외과학회(ASPS)의 2024년 보고서에 따르면, 히알루론산(HA) 필러는 여전히 가장 수요가 많은 최소침습적 치료법 중 하나이며, 얼굴 윤곽을 다듬는 시술 건수는 530만 건을 넘어섰고, 그 중 158만 건이 입술 볼륨업 시술이었다고 합니다. 또한, 피부 제품의 새로운 첨단 기술 개발을 위한 R&D 투자 증가가 시장 성장을 견인하고 있습니다.
시장 확대의 주요 요인은 세계 고령화입니다. 주요 경제국에서는 노년층 인구가 증가하는 인구통계학적 변화가 일어나고 있으며, 눈에 보이는 노화 징후와 싸우고 젊음을 유지하기 위한 미용 제품에 대한 수요가 증가하고 있습니다. 그 결과, 노화로 인한 주름, 잔주름, 기타 피부 트러블을 눈에 띄게 줄여주는 주사제에 대한 수요가 크게 증가하고 있습니다. Simbo AI가 발표한 기사에 따르면, 40-54세 연령층이 전체 피부 필러 시술의 약 49%, 55-69세 연령층이 약 37%를 차지합니다. 이러한 경향은 덜 침습적인 미용 시술을 선택하는 노년층이 증가하고 있다는 것을 의미하며, 히알루론산 피부 필러의 채용 확대가 기대됩니다. 마찬가지로 호주의 2023년 세대 간 보고서에 따르면, 2050년까지 호주의 65-84세 인구는 2배 이상 증가하고, 85세 이상 인구는 4배 이상 증가할 것으로 예측됩니다. 이러한 인구통계학적 변화로 인해 노인들의 요구에 부응하는 전문 클리닉의 수가 증가하고 있습니다.
목차 제1장 조사 방법과 범위
제2장 주요 요약
제3장 히알루론산 기반 피부 필러 시장 변수, 동향 및 범위
시장 계통 전망
시장 역학
히알루론산 기반 피부 필러 시장 분석 툴
제4장 히알루론산 기반 피부 필러 시장 : 제품별 추정·동향 분석
히알루론산 기반 피부 필러 시장 : 제품별 변동 분석
히알루론산 기반 피부 필러 시장 : 제품별 전망
시장 규모 및 예측 및 동향 분석(2021-2033년)
단상 제품
듀플렉스 제품
제5장 히알루론산 기반 피부 필러 시장 : 용도별 추정·동향 분석
히알루론산 기반 피부 필러 시장 : 용도별 변동 분석
히알루론산 기반 피부 필러 시장 : 용도별 전망
시장 규모 및 예측 및 동향 분석(2021-2033년)
주름 제거
입술 볼륨 업
코성형술
기타
제6장 히알루론산 기반 피부 필러 시장 : 지역별 추정·동향 분석
대시보드 : 지역별
히알루론산 기반 피부 필러 시장 변동 분석 : 지역별
시장 규모 및 예측 및 동향 분석(2021-2033년)
북미
미국
캐나다
유럽
영국
독일
프랑스
이탈리아
스페인
덴마크
스웨덴
노르웨이
러시아
아시아태평양
일본
중국
인도
한국
호주
태국
싱가포르
말레이시아
대만
베트남
필리핀
라틴아메리카
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제7장 경쟁 구도
시장 진입 기업 분류
주요 기업 개요
Allergan
Galderma LaboratoriesL.P.
Merz Pharmaceuticals
Genzyme Corporation
Anika Therapeutics Inc.
LG Life Sciences
LTD(LG Chem)
Bio plus Co. Ltd.
Sculpt Luxury
Dermal Fillers Ltd.
Bioxis Pharmaceutical
Sinclair Pharma Laboratories
Vivacy
Bohus Biotech AB
KSM
영문 목차
Hyaluronic Acid-based Dermal Fillers Market Summary
The global hyaluronic acid-based dermal fillers market size was estimated to be worth USD 4.47 billion in 2024 and is projected to reach USD 11.00 billion by 2033, growing at a CAGR of 10.5% from 2025 to 2033. The primary factors driving the market growth are the rising demand for non-invasive aesthetic treatment procedures and increasing awareness regarding the application of HA in the beauty segment.
According to the American Society of Plastic Surgeons (ASPS) 2024 report, hyaluronic acid (HA) fillers remain one of the most in-demand minimally invasive treatments, with over 5.3 million procedures performed to enhance facial features, including 1.58 million lip enhancement treatments. In addition, the increased investment in R&D for novel advanced innovations in dermal products is driving the market's growth.
Themarket expansion is majorly influenced by the aging population worldwide. The large economies are experiencing demographic change as the number of people in the older age categories is rising, and the need for beauty products to fight the visible signs of aging and preserve a youthful look is increasing. As a result, there has been a substantial increase in the need for injectable that alleviate in a visible way wrinkles, fine lines, and other skin-related issues caused by aging. According to an article published by Simbo AI, those aged 40-54 comprise almost 49% of all dermal filler procedures, and the 55-69 age group makes up approximately 37% of the treatments. This pattern is indicative of an increasing number of older people opting for less invasive cosmetic treatments, which is expected to drive the adoption of hyaluronic acid dermal fillers. Similarly, as per the Australia's 2023 Intergenerational Report, by 2050, the country's population aged 65 to 84 years is projected to more than double, and the population of those aged 85 years & over is expected to quadruple. This demographic shift is increasing the number of specialized clinics that cater to the needs of the elderly.
Global Hyaluronic Acid-based Dermal Fillers Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global hyaluronic acid dermal fillers market report on the basis of product, application, and region:
Product Outlook (Revenue, Million, 2021 - 2033)
Single Phase Products
Duplex Products
Application Outlook (Revenue, Million, 2021 - 2033)
Wrinkle Removal
Lip Augmentation
Rhinoplasty
Others
Region Outlook (Revenue, Million, 2021 - 2033)
North America
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Russia
Asia Pacific
China
Japan
South Korea
Thailand
Australia
Singapore
Malaysia
Taiwan
India
Vietnam
Philippines
Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Hyaluronic Acid-based Dermal Fillers Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Hyaluronic Acid-based Dermal Fillers Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Hyaluronic Acid-based Dermal Fillers Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hyaluronic Acid-based Dermal Fillers Market: Product Movement Analysis
4.3. Hyaluronic Acid-based Dermal Fillers Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
4.5. Single-Phase Product
4.5.1. Single-Phase Product Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Duplex Products
4.6.1. Duplex Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Hyaluronic Acid-based Dermal Fillers Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hyaluronic Acid-based Dermal Fillers Market: Application Movement Analysis
5.3. Hyaluronic Acid-based Dermal Fillers Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
5.5. Wrinkle Removal
5.5.1. Wrinkle Removal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Lip Augmentation
5.6.1. Lip Augmentation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Rhinoplasty
5.7.1. Rhinoplasty Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Hyaluronic Acid-based Dermal Fillers Market Movement Analysis
6.3. Hyaluronic Acid-based Dermal Fillers Market: Regional Estimates & Trend Analysis by Device Class & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
6.5. North America
6.5.1. North America Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. Europe
6.5.5. Europe Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. UK
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement scenario
6.5.6.5. UK Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Germany
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement scenario
6.5.7.5. Germany Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. France
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement scenario
6.5.8.5. France Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Italy
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement scenario
6.5.9.5. Italy Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.10. Spain
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Reimbursement scenario
6.5.10.5. Spain Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.11. Denmark
6.5.11.1. Key Country Dynamics
6.5.11.2. Competitive Scenario
6.5.11.3. Regulatory Framework
6.5.11.4. Reimbursement scenario
6.5.11.5. Denmark Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.12. Sweden
6.5.12.1. Key Country Dynamics
6.5.12.2. Competitive Scenario
6.5.12.3. Regulatory Framework
6.5.12.4. Reimbursement scenario
6.5.12.5. Sweden Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.13. Norway
6.5.13.1. Key Country Dynamics
6.5.13.2. Competitive Scenario
6.5.13.3. Regulatory Framework
6.5.13.4. Reimbursement scenario
6.5.13.5. Norway Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.14. Russia
6.5.14.1. Key Country Dynamics
6.5.14.2. Competitive Scenario
6.5.14.3. Regulatory Framework
6.5.14.4. Reimbursement scenario
6.5.14.5. Russia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. Japan Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. China Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. India Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. South Korea Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Australia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Thailand Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.8. Singapore
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Singapore Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.9. Malaysia
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement scenario
6.6.9.5. Malaysia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.10. Taiwan
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Reimbursement scenario
6.6.10.5. Taiwan Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.11. Vietnam
6.6.11.1. Key Country Dynamics
6.6.11.2. Competitive Scenario
6.6.11.3. Regulatory Framework
6.6.11.4. Reimbursement scenario
6.6.11.5. Vietnam Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.12. Philippines
6.6.12.1. Key Country Dynamics
6.6.12.2. Competitive Scenario
6.6.12.3. Regulatory Framework
6.6.12.4. Reimbursement scenario
6.6.12.5. Philippines Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Brazil Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. Argentina Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.4. Mexico
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Mexico Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East & Africa
6.8.1. Middle East & Africa Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. South Africa Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Saudi Arabia Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement scenario
6.8.4.5. UAE Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Kuwait Hyaluronic Acid- based Dermal Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Allergan
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Galderma LaboratoriesL.P.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Merz Pharmaceuticals
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Genzyme Corporation
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Anika Therapeutics Inc.
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. LG Life Sciences
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. LTD (LG Chem)
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Bio plus Co. Ltd.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Sculpt Luxury
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Dermal Fillers Ltd.
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Bioxis Pharmaceutical
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Sinclair Pharma Laboratories
7.2.12.1. Company overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Vivacy
7.2.13.1. Company overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. Bohus Biotech AB
7.2.14.1. Company overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
관련자료
